Posterior reversible encephalopathy syndrome in patients with COVID-19
Top Cited Papers
Open Access
- 9 July 2020
- journal article
- research article
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 416, 117019
- https://doi.org/10.1016/j.jns.2020.117019
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Apparent diffusion coefficient reduction might be a predictor of poor outcome in patients with posterior reversible encephalopathy syndromeJournal of the Neurological Sciences, 2017
- Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndromeNeuroradiology, 2017
- Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questionsThe Lancet Neurology, 2015
- Vascular endothelial growth factor in systemic lupus erythematosus - correlations with disease activity and nailfold capillaroscopy changes.2015
- Vascular Endothelial Growth Factor Signaling in Hypoxia and InflammationJournal of Neuroimmune Pharmacology, 2014
- Posterior Reversible Encephalopathy Syndrome in Systemic Lupus ErythematosusJCR: Journal of Clinical Rheumatology, 2013
- Posterior Reversible Encephalopathy Syndrome and Eclampsia: Pressing the Case for More Aggressive Blood Pressure ControlMayo Clinic Proceedings, 2011
- Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical FeaturesAmerican Journal of Neuroradiology, 2008
- D-dimer Correlates With Proinflammatory Cytokine Levels and Outcomes in Critically Ill PatientsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2002
- A Reversible Posterior Leukoencephalopathy SyndromeThe New England Journal of Medicine, 1996